China is vulnerable to another COVID-19 wave due to lack of immunity, says top health advisor, Health News, ET HealthWorld

[ad_1]

BEIJING: China still faces a huge challenge of a potential second wave of COVID-19 infections, with a lack of immunity among a majority of Chinese, a top medical adviser in the country has warned.

Doctor Zhong Nanshan, the senior government official of the Chinese government on Saturday was quoted in an exclusive CNN reports as saying, “The majority of … Chinese at present are still susceptible to the Covid-19 infection due to (by) a lack of immunity.”

“We are facing (a) great challenge, it is no better than the foreign countries I think at the moment.”

Dr. Zhong is a well-known figure in China, who in 2003 became known as the “SARS hero” to fight the severe epidemic of acute respiratory syndrome. Even now, Zhong’s contribution is considered crucial in the country coronavirus response.

In addition, it was Dr. Zhong, who in January of this year confirmed on state broadcaster CCTV that COVID-19 can be transmitted between people.

“Right from the start they kept silent, and then I probably said we have (a larger) number of people infected,” Zhong said. “I didn’t believe in this result, so I (kept) asking, and then you have to give me the right number.”

Coronavirus first found in the Chinese city Wuhan has so far reported 82,000 COVID-19 cases in the country, with 4,633 fatalities, according to country data National Health Commission (NHC).

Mainland China reported six new imported cases of the coronavirus disease on Saturday, bringing the total number of imported cases to 1,698.

Earlier in the day, a healthcare professional emphasized the need to improve further testing capabilities in China. According to Xinhua News Agency, China is capable of performing 1.5 million nucleic acid tests for COVID-19 infections every day.

The National Health Commission has called on all qualified and registered medical institutions across the country to conduct nucleic acid testing since late January to deal with the rapid growth of COVID-19 cases, said Guo Yanhong, an official with the commission.

The next step is to increase the construction and management of laboratories, biosafety management and training of medical personnel, the official added.



[ad_2]

Source link